• Profile
Close

Mitomycin C 0.02 and 0.002% efficacy in preventing haze after photorefractive keratectomy

International Ophthalmology Jan 23, 2018

Coelho LM, et al. - During this study, experts comparatively examined the efficacy of mitomycin C (MMC) 0.002% vs MMC 0.02% for the prevention of haze after photorefractive keratectomy (PRK) in patients with myopia or myopic astigmatism. Findings revealed the efficacy of MMC 0.002% in its prevention. Since the long-term safety of MMC remained unproven, its use was recommended in a lower concentration, which would prevent potential complications.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay